Lipocine INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

13 Mar 2025

LPCN

10-K: Lipocine Inc. Reports Fiscal Year 2024 Results and Provides Business Update

Lipocine Inc. announces its financial results for the year ended December 31, 2024, and provides an update on its clinical development programs and commercialization efforts.

NASDAQ

7 Mar 2024

LPCN

Lipocine INC

10-K: Lipocine Inc. Files 10-K Annual Report, Outlines Strategic Focus on CNS Therapies and Partnership Opportunities

Lipocine Inc.'s 2023 10-K filing details a strategic shift towards CNS disorders, progress in clinical trials, and new licensing agreements, while also highlighting financial results and future plans.